The Israeli biotech trying to make damaged nerves grow again...

NurExone, an Israeli biotech firm, is developing an exosome-based therapy designed to repair spinal cord and optic nerve injuries.

The approach targets conditions where current medical treatments have provided few effective options.

PRO: see who's reacting and what you're missing. See the whole picture →